Rensen et al. [8] found that MPO deficiency can significantly reduce the activation of hepatic stellate cells, fibrosis development, and accumulation of hepatocyte damage, suggesting that MPO plays an important role in NETs and promotes NASH pathogenesis and progression. The gene discussed is MPO; the disease is metabolic dysfunction-associated steatohepatitis.